Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.03%427.06B | 4.46%1.71T | 1.99%408.61B | 9.07%402.78B | 17.16%1.64T | 440.7B | 18.51%424.42B | 25.37%400.63B | 24.27%369.27B | 35.34%1.4T |
| Cost of revenue | 4.90%302.87B | 4.05%1.29T | 2.64%304.19B | 7.45%288.71B | 10.01%1.24T | 370.2B | 9.66%304.3B | 12.94%296.38B | 13.47%268.69B | 14.07%1.13T |
| Gross profit | 8.87%124.19B | 5.75%418.18B | 0.16%104.42B | 13.41%114.07B | 47.17%395.45B | 70.5B | 48.95%120.12B | 82.43%104.25B | 66.65%100.58B | 521.32%268.7B |
| Operating expense | 8.89%60.8B | 10.35%238.02B | 15.31%57.85B | 15.44%55.84B | 16.77%215.7B | 63.2B | 21.27%53.97B | 17.14%50.17B | 18.49%48.37B | 13.79%184.73B |
| Operating profit | 8.86%63.39B | 0.23%180.16B | -13.90%46.56B | 11.53%58.23B | 114.06%179.75B | 7.3B | 83.04%66.15B | 277.72%54.08B | 167.26%52.21B | 170.51%83.97B |
| Net non-operating interest income (expenses) | -5.73%-5.07B | 2.98%-19.45B | 4.78%-4.86B | 4.95%-4.8B | 3.52%-20.04B | -4.94B | 5.53%-4.96B | 3.26%-5.1B | 2.44%-5.05B | 2.69%-20.78B |
| Non-operating interest income | 208.33%37M | 14.04%65M | 15.38%15M | -20.00%12M | 39.02%57M | --13M | 100.00%16M | 18.18%13M | 66.67%15M | -59.41%41M |
| Non-operating interest expense | 6.24%5.11B | -2.94%19.51B | -4.73%4.88B | -5.00%4.81B | -3.43%20.1B | --4.95B | -5.37%4.97B | -3.22%5.12B | -2.32%5.06B | -2.96%20.82B |
| Net investment income | 0.92%550M | 16.43%2.83B | 242.86%96M | 31.64%545M | -4.52%2.43B | 1.57B | 14.36%414M | -30.00%28M | -28.50%414M | -44.67%2.54B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -20.98%388M | 17.19%1.62B | 48.41%932M | 19.76%491M | 25.48%1.38B | 242M | 106.25%99M | -6.27%628M | -5.09%410M | 7.53%1.1B |
| Special income (charges) | 408.97%3.57B | 94.67%-1.18B | 1,387.07%1.89B | 552.90%702M | -2,410.09%-22.2B | -22.04B | 120.92%141M | -116.76%-147M | -103.58%-155M | -93.86%961M |
| Less:Other special charges | -408.97%-3.57B | -124.10%-4.25B | -1,387.07%-1.89B | -552.90%-702M | 2,261.98%17.64B | --17.48B | -120.92%-141M | 116.76%147M | 103.58%155M | 104.83%747M |
| Less:Write off | ---- | 19.29%5.44B | ---- | ---- | 366.74%4.56B | ---- | ---- | ---- | ---- | -887.28%-1.71B |
| Other non-operating income (expenses) | -42.06%449M | -86.82%510M | 226.84%621M | 20.53%775M | -23.72%3.87B | 2.17B | 5.35%866M | -81.71%190M | -58.17%643M | -62.70%5.07B |
| Income before tax | 13.10%63.28B | 13.30%164.49B | -8.93%45.25B | 15.40%55.95B | 99.23%145.18B | -15.69B | 99.40%62.71B | 325.67%49.68B | 128.25%48.48B | 169.03%72.87B |
| Income tax | -20.09%13.58B | 12.45%45.88B | -8.98%13.38B | 23.58%16.99B | 294.33%40.8B | -6.43B | 170.94%18.79B | 233.83%14.7B | 136.78%13.75B | -504.49%-21B |
| Net income | 27.59%49.7B | 13.63%118.6B | -8.91%31.87B | 12.17%38.95B | 11.19%104.38B | -9.26B | 79.16%43.93B | 381.30%34.99B | -40.77%34.73B | 184.75%93.87B |
| Net income continuous operations | 27.59%49.7B | 13.63%118.61B | -8.90%31.87B | 12.17%38.95B | 11.20%104.38B | ---9.26B | 79.17%43.93B | 381.29%34.99B | -40.77%34.73B | 184.75%93.87B |
| Noncontrolling interests | 25.77%854M | -17.30%4.65B | -62.68%431M | -51.95%679M | 5.15%5.62B | 1.87B | -28.88%1.18B | 85.10%1.16B | 86.66%1.41B | 119.56%5.34B |
| Net income attributable to the company | 27.62%48.84B | 15.39%113.96B | -7.07%31.44B | 14.89%38.27B | 11.56%98.76B | -11.13B | 87.03%42.75B | 409.10%33.83B | -42.44%33.31B | 178.21%88.53B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 27.62%48.84B | 15.39%113.96B | -7.07%31.44B | 14.89%38.27B | 11.56%98.76B | -11.13B | 87.03%42.75B | 409.10%33.83B | -42.44%33.31B | 178.21%88.53B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 32.28%104.54 | 18.48%240.08 | -13.83%66.55 | 15.63%79.03 | 11.56%202.63 | -22.83 | 70.34%79.88 | 465.58%77.23 | -42.42%68.35 | 170.39%181.63 |
| Diluted earnings per share | 32.28%104.54 | 18.48%240.08 | -4.12%66.55 | 15.63%79.03 | 11.56%202.63 | -22.83 | 70.42%79.88 | 409.35%69.4132 | -42.42%68.35 | 170.39%181.63 |
| Dividend per share | 0 | 19.01%84.5 | 28.70%37 | 0 | 13.60%71 | 42.25 | 0 | 15.00%28.75 | 0 | 25.00%62.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |